Content Details
H.R. 2375 (IH) - Preserve Access to Affordable Generics and Biosimilars Act
- Category
- Bills and Statutes
- Collection
- Congressional Bills
- SuDoc Class Number
- Y 1.6:
Y 1.4/6:
- Congress Number
- 116th Congress
- Congress Session
- 1st Session
- Last Action Date Listed
- April 29, 2019
- Action
- Mr. Nadler (for himself, Mr. Collins of Georgia, and Mr. Cicilline) introduced the following bill; which was referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
- Bill Number
- H.R. 2375
- Bill Version
- Introduced in House (IH)
- Short Title
- Preserve Access to Affordable Generics and Biosimilars Act
- Full Title
- To prohibit prescription drug companies from compensating other prescription drug companies to delay the entry of a generic drug, biosimilar biological product, or interchangeable biological product into the market.
- Sponsors
- Jerrold Nadler(NY)
- Cosponsors
- Doug Collins (GA); David N. Cicilline (RI)
- Committees
- Committee on Energy and Commerce (Standing), Committee on the Judiciary (Standing)
- United States Code References
- 15 U.S.C. 1, 12, 44, 45, 56
and
57c-2
21 U.S.C. 355, 355, 355a and 360cc
42 U.S.C. 262 and 262
Loading...
Loading...